Trial Profile
An open-labelled, non-randomized controlled study of nitric oxide inhalation in cystic fibrosis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions; Therapeutic Use
- 30 Jul 2015 New trial record